N.Y. Comp. Codes R. & Regs. Tit. 10 § 58-2.19 - Records to be kept when derivatives are infused

The following information shall be included on the recipient's chart or in records maintained in the blood bank or pharmacy:

(a) product name, manufacturer, lot number, and expiration date;

(b) documentation of visual inspection prior to infusion;

(c) name of person administering the product;

(d) documentation of identification of the recipient;

(e) date of infusion and quantity of material infused; and

(f) description of any adverse reaction and the results of related investigation.

Notes

N.Y. Comp. Codes R. & Regs. Tit. 10 § 58-2.19

Amended New York State Register July 29, 2015/Volume XXXVII, Issue 30, eff. 9/27/2015